Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05739656 · ClinicalTrials.gov registry record
Evaluation of Visual Acuity of the Envista One-piece Acrylic Toric IOL MX60ET
A clinical trial, sponsored by Bausch & Lomb Incorporated.
- Completed
- Registry status
- 100
- Enrollment target
NCT05739656 is a clinical trial that has completed, run by Bausch & Lomb Incorporated. The registered enrollment target is 100 participants.
The verdict
NCT05739656 has completed, sponsored by Bausch & Lomb Incorporated.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
The primary objective of this study is to evaluate rotational stability and functional improvements in visual acuity of the enVista monofocal Toric IOL (MX60ET) following cataract surgery.
Interventions
- PROCEDURE CATARACT SURGERY
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2020-08-01 |
| Est. Completion | 2022-07-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05739656
The ClinicalTrials.gov registry entry for NCT05739656 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bausch & Lomb Incorporated, which has 174 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CATARACT SURGERY is the first listed.
NCT05739656 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05739656 about?
NCT05739656 is a clinical study titled "Evaluation of Visual Acuity of the Envista One-piece Acrylic Toric IOL MX60ET". The primary objective of this study is to evaluate rotational stability and functional improvements in visual acuity of the enVista monofocal Toric IOL (MX60ET) following cataract surgery.
What is the current status of trial NCT05739656?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2020-08-01. Estimated completion is 2022-07-06.
What interventions are being tested in trial NCT05739656?
The interventions under investigation include: CATARACT SURGERY (PROCEDURE).
Who is sponsoring clinical trial NCT05739656?
This trial is sponsored by Bausch & Lomb Incorporated, which has 174 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.